Multiple Assemblies exist for SMTL entry 4tyd
Structure-based design of a novel series of azetidine inhibitors of the hepatitis C virus NS3/4A serine protease; X-RAY DIFFRACTION 2.84 Å

	SMTL ID 4tyd.1 Ligands ZINC ION; (4R,6S,7Z,15S,17S)-17-[({7-methoxy-2-[4-(propan-2-yl)-1,3-thiazol-2-yl]quinolin-4-yl}oxy)methyl]-13-methyl-N-[(1-methylcyclopropyl)sulfonyl]-2,14-dioxo-1,3,13-triazatricyclo[13.2.0.0~4,6~]heptadec-7-ene-4-carboxamide; CHLORIDE ION Polypeptides NS3 protease Oligo-state homo-trimer
	SMTL ID 4tyd.2 Ligands ZINC ION; (4R,6S,7Z,15S,17S)-17-[({7-methoxy-2-[4-(propan-2-yl)-1,3-thiazol-2-yl]quinolin-4-yl}oxy)methyl]-13-methyl-N-[(1-methylcyclopropyl)sulfonyl]-2,14-dioxo-1,3,13-triazatricyclo[13.2.0.0~4,6~]heptadec-7-ene-4-carboxamide; CHLORIDE ION Polypeptides NS3 protease Oligo-state homo-trimer
	SMTL ID 4tyd.3 Ligands ZINC ION; (4R,6S,7Z,15S,17S)-17-[({7-methoxy-2-[4-(propan-2-yl)-1,3-thiazol-2-yl]quinolin-4-yl}oxy)methyl]-13-methyl-N-[(1-methylcyclopropyl)sulfonyl]-2,14-dioxo-1,3,13-triazatricyclo[13.2.0.0~4,6~]heptadec-7-ene-4-carboxamide; CHLORIDE ION Polypeptides NS3 protease Oligo-state homo-trimer
	SMTL ID 4tyd.4 Ligands ZINC ION; (4R,6S,7Z,15S,17S)-17-[({7-methoxy-2-[4-(propan-2-yl)-1,3-thiazol-2-yl]quinolin-4-yl}oxy)methyl]-13-methyl-N-[(1-methylcyclopropyl)sulfonyl]-2,14-dioxo-1,3,13-triazatricyclo[13.2.0.0~4,6~]heptadec-7-ene-4-carboxamide Polypeptides NS3 protease Oligo-state homo-trimer